Device Trial Radar · NCT06891729
Plan A Novel Delivery Device Study
Last checked: Nov 20, 2026Latest source record: Nov 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Mar 15, 2025
Primary completion
Jun 29, 2025
Study completion Jun 30, 2025
Sponsor
- Lead sponsor
- Next Life SciencesNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Southern Star Research
- First posted
- Mar 24, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- Male only, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and usability of the Delivery Lumen Access Device (DLAD) in accessing the vas deferens in up to 30 healthy males. This is a prospective, non-randomized, open label interventional study.
Conditions
- Healthy Male Adults Participants
- Vasectomy
Interventions
Delivery Lumen Access DeviceDevice
Delivery Lumen Access Device use prior to Vasectomy
DLADDevice
Participants will be exposed to the DLAD during their planned vasectomy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: 14 days post vasectomy procedure.
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Epworth HealthCare
Melbourne, Victoria, Australia
VasectoPro
Québec, Quebec/Canada, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.